RSS   Newsletter   Contact   Advertise with us
Post Online Media

RXI Pharma names Gerrit Dispersyn chief development officer

RXI PharmaRXi Pharmaceuticals Corporation, a biotechnology company, announced that Gerrit Dispersyn has been appointed as chief development officer, effective April 24, 2017.

Dr. Dispersyn most recently served as the Vice President, Global Head of Clinical Affairs at Integra LifeSciences Corporation.

READ MORE RXi Pharmaceuticals appoints two new directors

Prior to that role, Dr. Dispersyn was the Vice President, Product Development & Portfolio Management for Barrier Therapeutics.

Dr. Dispersyn is the founder of Ingress, LLC, a consultancy company providing R&D and clinical operations support to start-up companies, supporting several pharmaceutical drug development programs.

Dr. Dispersyn holds a Dr. Med. Sc. (Ph.D. in Medical Sciences), from the Faculty of Medicine, Maastricht University, Maastricht, the Netherlands, a post-graduate degree in Biomedical Imaging, and a M.Sc. in Biochemistry, both from the University of Antwerp, Belgium.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy